The case for Option B and Optional B+: Ensuring that South Africa’s commitment to eliminating mother-to-child transmission of HIV becomes a reality
Journal Article
2012
Permanent link to this Item
Authors
Journal Title
Southern African Journal of Hiv Medicine
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher
Faculty
License
Series
Abstract
In a previous issue of the Southern African Journal of HIV Medicine, Pillay and Black summarised the trade-offs of the safety of efavirenz use in pregnancy (Pillay P, Black V. Safety, strength and simplicity of efavirenz in pregnancy. Southern African Journal of HIV Medicine 2012;13(1):28-33.). Highlighting the benefits of the World Health Organization’s proposed options for the prevention of mother-to-child transmission (PMTCT) of HIV, the authors argued that the South African government should adopt Option B as national PMTCT policy and pilot projects implementing Option B+ as a means of assessing the individual- and population-level effect of the intervention. We echo this call and further propose that the option to remain on lifelong antiretroviral therapy, effectively adopting PMTCT Option B+, be offered to pregnant women following the cessation of breastfeeding, for their own health, following the provision of counselling on associated benefits and risks. Here we highlight the benefits of Options B and B+.
Description
Reference:
Besada, D., Van Cutsem, G., Goemaere, E., Ford, N., Bygrave, H. & Lynch, S. 2012. The case for Option B and Optional B+: Ensuring that South Africa’s commitment to eliminating mother-to-child transmission of HIV becomes a reality. Southern African Journal of Hiv Medicine. 13(4):174 - 177. http://hdl.handle.net/11427/34822